European biotech
Nestlé and Seres announce new partnership for C.diff microbiome therapeutic
The companies will jointly commercialise Seres’ investigational oral microbiome therapeutic in the US and Canada
eureKARE to use $60m financing to bolster next-generation European biotech companies
New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology
Can Science Save Us?
Dr. Mark Poznansky, Founder/Blogger at Saved By Science explores the importance of improving health literacy among the general population, along with the scientific and technological innovations that he believes could help save...
Seres’ microbiome-based therapy hits the mark in phase 3
Drug reduced C.difficile infection recurrence
European biotech: a new generation of leaders emerges
Three companies that are on the rise in biotech
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK
Novartis and J&J back latest €400m Medicxi biopharma fund
Growing appetite from European investors to back early-stage biotechs
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region
Gilead strikes $5.1bn deal to bolster ties with Galapagos
Big boost for Belgian biotech, without a buy-out
BioNTech raises €290m for mRNA cancer vaccine platform
Funds will help lead melanoma candidate progress
Citryll snares €15m backing for its autoimmune disease NETs
New approach to tackling diseases such as lupus, RA